About PenCol Specialty Pharmacy
PenCol Specialty Pharmacy is a company based in Denver (United States) founded in 2021 was acquired by Revelation Pharma in January 2022. PenCol Specialty Pharmacy operates in a competitive market with competitors including Fagron, Ignota Labs, RareStone Group, Revelation Pharma and Pharmedium, among others.
- Headquarter Denver, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Revelation Pharma
(Jan 27, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of PenCol Specialty Pharmacy
Detailed funding history for PenCol Specialty Pharmacy
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in PenCol Specialty Pharmacy
PenCol Specialty Pharmacy has secured backing from 1 investor. Prominent investors backing the company include Revelation Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A network of compounding pharmacies is operated nationwide.
|
Locked | Locked | Locked |
Investor details for PenCol Specialty Pharmacy
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PenCol Specialty Pharmacy
Investment portfolio details for PenCol Specialty Pharmacy
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - PenCol Specialty Pharmacy
Detailed financials for PenCol Specialty Pharmacy
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pencol Specialty Pharmacy Comparisons
Peer comparison for PenCol Specialty Pharmacy
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PenCol Specialty Pharmacy
PenCol Specialty Pharmacy operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Fagron, Ignota Labs, RareStone Group, Revelation Pharma and Pharmedium, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Drug compounding services are provided by Fagron.
|
|
| Locked | Locked | Locked |
AI-driven toxicity prediction tools for early-stage drug discovery scientists
|
|
| Locked | Locked | Locked |
Provider of network and treatments to individuals and their families affected by rare diseases drugs
|
|
| Locked | Locked | Locked |
A network of compounding pharmacies is operated nationwide.
|
|
| Locked | Locked | Locked |
Drug compounding services are provided to healthcare facilities nationwide.
|
|
| Locked | Locked | Locked |
Drug compounding services are provided by Syntis in healthcare.
|
Detailed competitors of PenCol Specialty Pharmacy
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pencol Specialty Pharmacy
Complete news archive for PenCol Specialty Pharmacy
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PenCol Specialty Pharmacy
PenCol Specialty Pharmacy was founded in 2021.
PenCol Specialty Pharmacy is headquartered in Denver, United States. It is registered at Denver, Colorado, United States.
PenCol Specialty Pharmacy was founded in 2021 and is based in Denver, United States. Operations center on drug compounding within the specialty pharmacy sector. Customized medications are prepared to meet specific patient requirements. Ownership is attributed to Tony E Jones. Services are delivered in the healthcare field, with a geographic emphasis on the local U.S. market. Standard pharmaceutical protocols are followed to ensure compliance and efficacy.
PenCol Specialty Pharmacy's top competitors include Syntis, Ignota Labs and Fagron.
PenCol Specialty Pharmacy has 1 investor. Key investors include Revelation Pharma.